Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin
- PMID: 11883643
- DOI: 10.1023/a:1014208515545
Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin
Abstract
Purpose: The purpose of the present research was to study 10 m-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid-potential local anesthetics. The relationships between the structure of the molecule, its physicochemical parameters (log D(oct), log k, R(M), solubility) were correlated to the permeability data obtained from permeation experiments in Caco-2 monolayers and excised human skin in vitro.
Methods: The extent and mechanism(s) of permeability of the series were studied through a Caco-2 monolayer in the apical-to-basolateral (a-b) and basolateral-to-apical (b-a) directions. The MTT test was performed to determine cellular damage. In vitro transdermal permeability data were obtained from permeation experiments on excised human skin by using side-by-side chambers. Passive diffusion and iontophoretically enhanced permeability were measured.
Results: In Caco-2 monolayers, similar results in the shape of the permeability curves were obtained for the two directions. In the b-a direction, the values of P(app) were approximately 2-6 times greater than in the a-b direction. A plot of drug permeability vs. the number of carbons in the alkoxychain plateaued first, after which the permeability decreased by the increasing lipophilicity of the drug. If the log D(oct) of the ester was > or = 3.4 and the MW > 385 Da, no measurable Caco-2 permeability was found. Cell damage was also higher by the more lipophilic compounds. In excised human skin, the relationship between the passive diffusion of the drugs and the number of carbons in the alkoxychain was parabolic (r2 = 0.95). Introducing low-level electrical current (iontophoresis), transdermal permeability of the more hydrophilic phenylcarbamic acid esters increased clearly.
Conclusions: Lipophilicity and solubility of a compound have crucial roles in the permeation process. A very high lipophilicity has, however, a negative influence on the permeability, both intestinally and transdermally. Iontophoresis significantly increases the diffusion of small and less lipophilic compounds.
Similar articles
-
Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.Eur J Pharm Sci. 1998 Oct;6(4):317-24. Eur J Pharm Sci. 1998. PMID: 9795088
-
Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.J Pharmacol Exp Ther. 2003 Dec;307(3):1112-9. doi: 10.1124/jpet.103.056135. Epub 2003 Oct 13. J Pharmacol Exp Ther. 2003. PMID: 14557377
-
Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.Curr Drug Deliv. 2009 Jul;6(3):280-90. doi: 10.2174/156720109788680895. Curr Drug Deliv. 2009. PMID: 19604142
-
Transdermal drug delivery systems: skin perturbation devices.Methods Mol Biol. 2008;437:119-39. doi: 10.1007/978-1-59745-210-6_5. Methods Mol Biol. 2008. PMID: 18369965 Review.
-
Transdermal drug delivery by passive diffusion and iontophoresis: a review.Med Res Rev. 1993 Sep;13(5):569-621. doi: 10.1002/med.2610130504. Med Res Rev. 1993. PMID: 8412408 Review. No abstract available.
Cited by
-
N-in-one permeability studies of heterogeneous sets of compounds across Caco-2 cell monolayers.Pharm Res. 2003 Feb;20(2):187-97. doi: 10.1023/a:1022262818573. Pharm Res. 2003. PMID: 12636156
-
Design for optimized topical delivery: Prodrugs and a paradigm change.Pharm Res. 2006 Dec;23(12):2729-47. doi: 10.1007/s11095-006-9108-0. Epub 2006 Nov 16. Pharm Res. 2006. PMID: 17109215 Review.
-
The 3C (Cell Culture, Computer Simulation, Clinical Trial) Solution for Optimizing the 3R (Replace, Reduction, Refine) Framework during Preclinical Research Involving Laboratory Animals.ACS Pharmacol Transl Sci. 2025 Apr 9;8(5):1188-1204. doi: 10.1021/acsptsci.4c00661. eCollection 2025 May 9. ACS Pharmacol Transl Sci. 2025. PMID: 40370984 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources